Avantor, Inc. $AVTR Shares Sold by Robeco Schweiz AG

Robeco Schweiz AG cut its position in Avantor, Inc. (NYSE:AVTR) by 9.2% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 7,920,177 shares of the company’s stock after selling 807,007 shares during the quarter. Avantor comprises about 2.2% of Robeco Schweiz AG’s portfolio, making the stock its 9th biggest holding. Robeco Schweiz AG owned approximately 1.16% of Avantor worth $98,844,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently modified their holdings of the business. EverSource Wealth Advisors LLC raised its stake in Avantor by 119.1% during the second quarter. EverSource Wealth Advisors LLC now owns 2,187 shares of the company’s stock worth $29,000 after acquiring an additional 1,189 shares in the last quarter. Strategic Wealth Investment Group LLC bought a new stake in shares of Avantor in the second quarter worth $32,000. FNY Investment Advisers LLC acquired a new stake in shares of Avantor in the second quarter valued at about $36,000. Osaic Holdings Inc. lifted its holdings in Avantor by 60.9% in the second quarter. Osaic Holdings Inc. now owns 2,810 shares of the company’s stock valued at $38,000 after buying an additional 1,064 shares during the period. Finally, Spire Wealth Management bought a new position in shares of Avantor during the 2nd quarter worth about $47,000. Institutional investors own 95.08% of the company’s stock.

Avantor Stock Performance

Shares of AVTR stock opened at $12.59 on Wednesday. The firm’s 50 day moving average is $11.47 and its 200 day moving average is $12.57. The stock has a market capitalization of $8.58 billion, a P/E ratio of -96.81, a PEG ratio of 4.25 and a beta of 0.93. Avantor, Inc. has a 12 month low of $10.62 and a 12 month high of $23.32. The company has a current ratio of 1.49, a quick ratio of 0.96 and a debt-to-equity ratio of 0.65.

Avantor (NYSE:AVTR) last issued its earnings results on Wednesday, October 29th. The company reported $0.22 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.23 by ($0.01). Avantor had a negative net margin of 1.25% and a positive return on equity of 10.91%. The business had revenue of $1.62 billion for the quarter, compared to the consensus estimate of $1.65 billion. During the same period in the previous year, the firm earned $0.26 EPS. The company’s revenue was down 5.3% compared to the same quarter last year. Avantor has set its FY 2025 guidance at 0.880-0.920 EPS. On average, sell-side analysts anticipate that Avantor, Inc. will post 1.06 earnings per share for the current year.

Insider Activity

In other news, Director Gregory L. Summe acquired 100,000 shares of Avantor stock in a transaction that occurred on Thursday, October 30th. The stock was bought at an average price of $11.25 per share, with a total value of $1,125,000.00. Following the completion of the purchase, the director owned 300,000 shares in the company, valued at approximately $3,375,000. The trade was a 50.00% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Sanjeev K. Mehra purchased 350,000 shares of the firm’s stock in a transaction dated Friday, December 5th. The stock was purchased at an average cost of $11.09 per share, for a total transaction of $3,881,500.00. Following the acquisition, the director owned 350,000 shares of the company’s stock, valued at approximately $3,881,500. This trade represents a ∞ increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. 1.20% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

A number of brokerages have commented on AVTR. Zacks Research raised Avantor from a “strong sell” rating to a “hold” rating in a research note on Monday, December 29th. Robert W. Baird boosted their price target on shares of Avantor from $15.00 to $17.00 and gave the company an “outperform” rating in a research note on Friday, October 24th. Raymond James Financial lowered shares of Avantor from an “outperform” rating to a “market perform” rating in a research note on Tuesday, November 4th. Bank of America lowered shares of Avantor from a “buy” rating to a “neutral” rating and set a $13.00 target price on the stock. in a report on Monday, December 15th. Finally, Barclays reissued an “equal weight” rating and issued a $12.00 price objective (down from $15.00) on shares of Avantor in a research note on Thursday, October 30th. Three analysts have rated the stock with a Buy rating, thirteen have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average target price of $13.60.

Avantor Company Profile

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.